Monday, November 24, 2025




In Detail Full day, Monday, November 24, 2025, Timezone: America/Chicago


FDA Approves Pembrolizumab + Enfortumab Vedotin-ejfv for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer / OncoDaily

oncodaily - What Does FDA Approval Mean? The U.S. Food and Drug Administration (FDA) evaluates new cancer therapies to determine whether they are safe and effective for clinical use. Approval is based […]

#healthcare #pharmaceuticals #publichealth #drugdevelopment #fda


Monday, November 24, 2025, 10:23 am / permalink 16257 / 2 stories in 3 months


M. Tezer Kutluk: 2025 Update of World Cancer Declaration with UICC Board / OncoDaily

oncodaily - M. Tezer Kutluk, Professor of Pediatrics and Pediatric Oncologists, Chair of the Scientific Board at Medicana Health Group, shared a post on LinkedIn: “Dear friends, Between 18–20 November 2025 in Melbourne, […]

#healthcare #publichealth


Geriatric Oncology Updates


Global Cancer Leadership & Policy


Innovative Cancer Treatment & Research


Other Cancer & Related Topics


Monday, November 24, 2025, 4:21 am / permalink 16241 / 47 stories in 3 months


StackHealth Time Machine




Outgoing Stories


HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 18.6 hours

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 19.6 hours

Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 21.6 hours

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 22.6 hours

FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 34.6 hours

HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 47.6 hours

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 50.6 hours

Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 51.6 hours

Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 56.6 hours

AI improves UK breast-screening detection by about 10% 5 stories in 56.6 hours


More StackHealth


Bluesky:



NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.